Elevated blood pressure predicts risk of acute rejection in renal allograft recipients  by Guidi, Ettore
Kidney International, Vol. 60 (2001), pp. 801–803
LETTERS TO THE EDITOR
Imperial College of Science Technology and Medicine, Royal Brompton
Hospital, Sydney Street, London SW3 6NP, United Kingdom.Need for publication
E-mail: info-www@2aida.org
of all studies testing
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I was invited to Sydney by the main proponent of the Reply from the author
SphygoCor device to undertake research in 1995 and I understand that Dr. Lehmann has significant reserva-
again in 1996 [abstract; Plunkett BT, et al, Z Kardiol 85 tions about the validation of the SphygmoCor apparatus.
(Suppl 3):136, 1996)]. While there, I observed actual I do not share them. Let history (that is, future valida-
intra-aortic blood pressures being recorded during car- tions, which I call for as fervently as he does) be the
diac catherization in 15 patients, simultaneously with judge.
noninvasive SphygmoCor device measurements. The lat-
ter method did not provide me with great confidence in David J.A. Goldsmith, for the authors
the use of the device for predicting central aortic blood London, England, United Kingdom
pressure because the errors associated with the Sphyg-
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Furthermore, during my second trip, I was made aware London, SEI 9RT England, United Kingdom.
of details of two additional studies that had also sought
to test the SphygmoCor device. Both used invasive intra-
arterial blood pressure data to recalibrate the noninva-
sively recorded SphygmoCor waveforms. Both studies Elevated blood pressure
demonstrated that the SphygmoCor device had substan-
tial and increasing errors with increasing blood pressure predicts risk of acute rejection
values. Therefore, the device appeared least accurate in
hypertensive patients. in renal allograft recipients
None of these studies has been published, which is
the reason I have felt a responsibility to the scientific
To the Editor: The findings in the paper by Cosio et alcommunity to generate some discussion about the inac-
[1] are reminiscent of our data on the transmission ofcuracies inherent in this approach [2, 3], especially since
familial hypertension via the donor’s kidney and its rela-some researchers have begun to apply the methodology
tionship with a higher vulnerability to kidney damage.with no validation data to support its use.
While Cosio et al showed that in renal transplantedDr. Goldsmith will surely join me in calling for data
patients arterial hypertension identifies patients at higherfrom all these studies, which date back to 1995 and 1996,
risk of acute rejections independently from renal func-to be made public so that researchers can draw their
tion and other variables known to be associated withown conclusions about the accuracy of the technique.
greater occurrence of acute rejections, in a similar study
Eldon D. Lehmann equally restricted to the first year after transplantation,
London, England, United Kingdom we showed that familiality for hypertension in the donor
not only determined a higher requirement for antihyper-Correspondence to Dr. Eldon D. Lehmann, M.B., B.S., B.Sc., De-
tensive therapy in the recipient [2], but also a greaterpartment of Imaging (MR Unit), National Heart and Lung Institute,
kidney involvement during an acute rejection episode
(as judged by blood pressure level and serum creatinine
increase), without increasing the number of acute rejec- 2001 by the International Society of Nephrology
801
Letters to the Editor802
tions [3]. A possible explanation for the results of Cosio blood pressure post-transplant may be related to (1)
graft damage during preservation; (2) preexisting graftet al is that hypertension and a greater susceptibility to
vascular damage in the donor prior to donation and duerenal damage in their recipients are both transmitted, at
to hypertension; or (3) other genetic characteristics ofleast in part, by the donor kidney. This theory would be
the donor graft in patients with familial hypertensioninteresting to investigate, if data on the donors of those
[3]. The data presented in our recent paper [1] are atpatients are available. The difference between an in-
least partially consistent with the postulate that the do-crease in rejection number and their greater severity is,
nor graft also determines, in part, the risk of rejection.in my opinion, a minor point. The important issue, in-
However, it is much more difficult for us to postulatestead, is the intriguing association between the renal
a plausible pathogenic mechanism for this association,phenotypic expression of “hypertensive gene(s)” and the
unless it is the hypertension itself, causing endothelialgreater susceptibility to an immunologic challenge, both
changes, that predisposes to immune phenomena.transmitted via the donor’s kidney. Other studies have
revealed relationships between familiality for hyperten-
Fernando G. Cosiosion and involvement of the kidney in diabetes [4] and
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IgA nephropathy [5], indicating pleiotropic effects of
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of Dheenan and Henrich [1], in which the effects ofd’hypertension arterielle est associee a la survenue d’une hyperten-
sion arterielle et d’une nephro-angiosclerose chez les patients at- sodium modeling, high sodium dialysis, cool temperature
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Coeur Vaisseaux 89:1065–1068, 1996
tension were compared. The authors suggest that sodium
modeling and cool temperature dialysis should be used
Reply from the author as a first-line step in the prevention of intradialytic hypo-
I read with interest Dr. Guidi’s comments about our tension with a higher dialysate sodium concentration as
recently published work in Kidney International [1]. Dr. a reasonable alternative.
Guidi postulates that the donor kidney may determine Indeed, we fully agree with the authors that isolated
both the risk of hypertension post-transplant and the ultrafiltration followed by isovolemic dialysis will certainly
risk for rejection. Consistent with the first portion of have a disadvantage over cool temperature dialysis, which
this hypothesis, we showed previously that the blood is understandable. The initial ultrafiltration rate was much
pressure levels in pairs of individuals who receive kid-
neys from the same donor are highly correlated [2]. The
pathogenic link between donor graft and recipient’s  2001 by the International Society of Nephrology
